Historique
Rapport
Preventing opioid overdose deaths with take-home naloxone
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
STRANG, J. ;
McDONALD, R. ;
HEDRICH, D. ;
SIMON, R.
Année
2016
Page(s) :
104 p.
Langue(s) :
Anglais
Collection :
Insights
ISBN :
978-92-9168-837-1
Domaine :
Drogues illicites / Illicit drugs
Thésaurus géographique
EUROPE
;
INTERNATIONAL
Organismes
OEDT
Thésaurus mots-clés
NALOXONE
;
SURDOSE
;
PREVENTION
;
VOIE D'ADMINISTRATION
;
MORTALITE
;
HISTOIRE
;
SECURITE SANITAIRE
;
URGENCE
;
FORMATION
;
PROGRAMME
;
POLITIQUE
;
ECHELLE D'EVALUATION
;
OPIOIDES
Note de contenu :
TABLE OF CONTENTS:
Introduction.
Chapter 1: Pharmacology and physiological mechanisms of opioid overdose and reversal.
Chapter 2: Emergency naloxone in regular clinical practice.
Chapter 3: Opioid overdose deaths: risks and clusterings in time and context.
Chapter 4: Historical summary of the development and spread of take-home naloxone provision.
Chapter 5: Setting up take-home naloxone training and distribution programmes.
Chapter 6: Options for the future: new products, new legislation, new initiatives.
Introduction.
Chapter 1: Pharmacology and physiological mechanisms of opioid overdose and reversal.
Chapter 2: Emergency naloxone in regular clinical practice.
Chapter 3: Opioid overdose deaths: risks and clusterings in time and context.
Chapter 4: Historical summary of the development and spread of take-home naloxone provision.
Chapter 5: Setting up take-home naloxone training and distribution programmes.
Chapter 6: Options for the future: new products, new legislation, new initiatives.
Résumé :
This publication examines the case for distributing naloxone, an emergency medication, to people who inject opioids such as heroin and to others who might witness an opioid overdose. Through its capacity to reverse opioid overdose, naloxone can save lives if administered in time. This comprehensive review looks at opioid overdose and how naloxone counteracts it, and discusses the circumstances of opioid overdose deaths and the use of naloxone in regular clinical practice. As well as documenting the historical development and spread of take-home naloxone programmes in Europe and beyond, the study looks at the practical side of their implementation, including the training of naloxone recipients in how to recognise and respond to an overdose. Although take-home naloxone is supported by the World Health Organization, the report finds that barriers to its access exist in Europe and considers how the availability of the intervention may be expanded.
Affiliation :
National Addiction Centre, Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK